BTRCF yields 17.14% · PFE yields 6.13%● Live data
📍 BTRCF pulled ahead of the other in Year 1
Combined, BTRCF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BTRCF + PFE for your $10,000?
Better Collective A/S, together with its subsidiaries, operates as a sports betting media company worldwide. The company primarily focuses on online sports betting and gambling platforms. It offers various community-based digital platforms, including bettingexpert.com, social network of sports betting tipsters; SpilXperten, a sports betting media platform; Action Network, a source for sports betting insights; Irishracing.com, a website, which provides coverage of Irish, British, and international horse racing; Speltips.se for betting tips; HLTV.org, a website for news from the e-sport industry, CS:GO match information, and player and team rankings; RotoGrinders for fantasy sports; Wettbasis, which provides betting tips for German betting enthusiasts; VegasInsider, a platform for betting tips and picks in the United States; Betarades, a platform for online betting news in Greece; PariuriX, a platform in Romania for finding the sports betting tips; ScoresAndOdds, a statistical analysis designed for sports bettors in the US; Wettfreunde, an iGaming Platform in the German language. In addition, it provides Sportwettentest, a bookmaker stress tester; Bonus Code Bets; SmartBets, a customizable odds comparison site; Bookmakers.tv, a site for bookmaker reviews and offers; Us-bookies.com, a platform dedicated to the American punter; Roulette Geeks, which offers educational materials that teach users about casino strategies; and Spelsidor.se, which provides information about bonuses, igaming companies and gambling news. Better Collective A/S was founded in 2004 and is headquartered in Copenhagen, Denmark.
Full BTRCF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.